RxDoctor Payments Data

Garrett Collins, MD

Internal Medicine · Augusta, GANPI 1699124818

Payments from drug & device makers

$6,846in general payments, 2019–2025

Across 98 payments — averaging $69.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$4K
  • GSK$554
  • Boehringer Ingelheim$289
  • AstraZeneca$206
  • Sanofi$201
  • United Therapeutics Corporation$172
  • plus $1K from 17 others

What the payments were for

  • Travel & lodging$2383%
  • Food & beverage$2,42935%
  • Education$4,17961%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,846 in reported general payments places this provider in the 90th percentile of 3,311 internal medicine providers in Georgia.

See all internal medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$28,522
Medicare patients
152
Services billed
310

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter54$35,830
Stiolto RespimatTiotropium Br/Olodaterol Hcl22$11,206
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr20$9,395
Breo ElliptaFluticasone/Vilanterol17$6,735
SymbicortBudesonide/Formoterol Fumarate22$4,663
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate15$2,104
Albuterol Sulfate HfaAlbuterol Sulfate87$2,094
Varenicline Tartrate12$1,951
Prednisone23$123
Montelukast Sodium25$112

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$554$51,96091 claims
Boehringer IngelheimStiolto Respimat$289$11,20622 claims
AstraZenecaSymbicort$206$4,66322 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,311 internal medicine providers in Georgia.

Other internal medicine in Augusta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →